title: Hot flashes--physiology, hormonal therapy, and alternative therapies.
abstract: Hormone replacement therapy should be discussed with every postmenopausal woman and should be the first therapy offered to treat hot flashes owing to its high efficacy and other beneficial properties. Women who are ineligible for or uncomfortable with estrogen replacement therapy and who suffer from hot flashes that interfere with the quality of life should be offered other regimens as discussed in this article.
authors.affiliation: Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: E S
authors.initials: ES
authors.lastname: Ginsburg
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D001533:Belladonna Alkaloids; D002979:Climacteric / Q000187:drug effects / Q000502:physiology / Q000523:psychology; D003937:Diagnosis, Differential; D004338:Drug Combinations; D004879:Ergotamines / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use; D015444:Exercise; D005260:Female; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D005894:Panax; D010634:Phenobarbital / Q000627:therapeutic use; D010946:Plants, Medicinal; D011372:Progestins / Q000627:therapeutic use
chemical_list: D000316:Adrenergic alpha-Agonists; D000728:Androgens; D001533:Belladonna Alkaloids; D004338:Drug Combinations; D004879:Ergotamines; D004967:Estrogens; D011372:Progestins; C044435:belladonna alkaloid, ergotamine, phenobarbital drug combination; D008784:Methysergide; D010634:Phenobarbital